Long-term treatment hereditary angioedema attenuated androgens survey experience Fifty-six patients hereditary angioedema long-term prophylaxis attenuated androgens treatment patients severe attacks month patients therapy years minimal effective dose mg/day stanozolol mg/day danazol patients doses sufficient complete disappearance symptoms Irregular menstruation amenorrhea significant side effect patient therapy laboratory signs hepatic cell necrosis patient danazol last weeks pregnancy side effects mother transient signs virilization female baby biochemical marker minimal effective dose androgen derivatives plasma levels INH complexes different doses stanozolol patients hereditary angioedema complexes treatment normal values androgen therapy normal reduction dose drug patient symptom free measurement INH complexes activity disease amount androgen 